Bass, Berry & Sims attorney Jeff Davis authored an article for the American Health Law Association (AHLA) discussing the Health Resources and Services Administration’s (HRSA) approval of a new 340B Rebate Pilot Program. Under the Pilot Program, drug manufacturers will be allowed to offer 340B-discounted drug prices through rebates for ten approved drugs in 2026. … Continued
| less than a minute read
Jeff Davis Discusses HRSA Approval of 340B Drug Rebate Plan


/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2026-07-07-18-33-08-485-6a4d4664387a16e328779c45.jpg)
/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2026-07-07-18-32-16-149-6a4d4630910ef05941a8570e.jpg)
/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2026-07-06-18-17-39-842-6a4bf143b62975e4c00509ba.jpg)